Covaxin has newborn calf serum? Centre busts myth on COVID-19 vaccine india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.
US pharmaceutical giant Pfizer has said that is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions. However, the US drugmaker has asked for relaxations in some clauses, including indemnification for its shots, sources informed.
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. The drugmaker has asked for relaxations in some clauses, sources informed.
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.
New Delhi [India], May 26 (ANI): US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday.